ArticleHealth science reports2024

The efficacy of immune checkpoint inhibitors following discontinuation for long-term response or toxicity in advanced or metastatic non-small-cell lung cancers: A retrospective study.

Laure Vacher et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.